MS. ASHLEY MICHELLE DAVIS NP
Prescription History 1265218580
Nurse Practitioner - Family in New York, NY

Active since September 01, 2023PECOS EnrolledAccepts Medicare Assignment
356 W 18TH ST, NEW YORK, NY 10011(122) 717-2002 Get Directions

NPPES record last updated: March 18, 2025. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Mar 18, 2025, Sep 1, 2023 (2 updates tracked since 2023).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. ASHLEY MICHELLE DAVIS NP, an active Family specialist practicing in New York, NY. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 28 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 16 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
28
Total Claims
30
30-Day Fills
Biktarvy
Most Prescribed · 16 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by MS. ASHLEY MICHELLE DAVIS NP in 2024, with prescription volumes, average cost per fill, and NY state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NY PrescribersVs. NY Avg
BiktarvyBictegrav/Emtricit/Tenofov Ala16$3,795.77▼ below NY avg▼ Less than typical

About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 16 Medicare prescriptions for Biktarvy, about 19% of the volume of the typical New York prescriber of this medication (83.3). Medicare paid an average of $3,795.77 per fill, versus $4,069.88 statewide.

How often this provider prescribes it

This provider
16
NY average
83.3

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3,795.77
NY average
$4,069.88

This provider's average cost per fill is below the NY average for this medication.

16
30-Day Fills
standardized to 30-day supplies
480
Days of Medication
total across all patients in 2024
Losartan Potassium12$2.74▼ below NY avg▼ Less than typical

About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾

It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

In 2024, this provider wrote 12 Medicare prescriptions for Losartan Potassium, about 11% of the volume of the typical New York prescriber of this medication (113). Medicare paid an average of $2.74 per fill, versus $9.47 statewide.

How often this provider prescribes it

This provider
12
NY average
113.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2.74
NY average
$9.47

This provider's average cost per fill is below the NY average for this medication.

14
30-Day Fills
standardized to 30-day supplies
420
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NY prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NY average cost per fill.

About this data. The prescription history for MS. ASHLEY MICHELLE DAVIS NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this New York, NY practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.